Gastroenterology13 min read

    Maximizing GI Practice Profitability: An Operational Playbook

    Gastroenterology practices have unique revenue opportunities from endoscopy to infusion services. Learn how to optimize operations and capture full practice potential.

    Peter KempManaging Partner
    13 min read

    Maximizing GI Practice Profitability: An Operational Playbook


    Gastroenterology offers exceptional opportunities for practice profitability, if you structure operations correctly. From endoscopy optimization to ancillary services, here's how successful GI practices maximize their potential.


    The GI Business Model


    Revenue Streams

  1. Professional services Office visits, consults
  2. Endoscopy procedures Colonoscopy, EGD, ERCP
  3. Facility fees If ASC-owned
  4. Infusion services Biologics for IBD
  5. Pathology If lab ownership
  6. Clinical research Pharma-sponsored trials

  7. The Endoscopy Engine

    Endoscopy is the profit center:

  8. Colonoscopy: $300-800 professional fee
  9. ASC facility fee: $1,000-2,500 additional
  10. Volume potential: 4-6 procedures per half-day block

  11. Endoscopy Suite Optimization


    Scheduling Efficiency

    Maximize throughput:

  12. 30-minute procedure slots for screening colonoscopy
  13. 45-minute slots for complex/therapeutic
  14. Stagger patient arrivals
  15. Parallel processing in prep and recovery

  16. Room Utilization

    Target metrics:

  17. 85%+ room utilization
  18. <15 minute turnover
  19. <10% case cancellation
  20. First case on-time start >90%

  21. Staffing Model

    Per-room staffing:

  22. 2 RNs/procedure room
  23. 1 tech per room
  24. Shared recovery staff
  25. Front desk support

  26. ASC Ownership in GI


    The Financial Case

    GI ASC economics:

  27. Average net per colonoscopy: $800-1,200
  28. Break-even: Often 2,500-3,500 procedures/year
  29. Typical margin: 30-45%

  30. Ownership Structures

    Options to consider:

  31. 100% physician-owned
  32. Joint venture with hospital
  33. Management company partnership
  34. Syndicated with other specialties

  35. Regulatory Compliance

    Critical requirements:

  36. State licensure
  37. Medicare certification
  38. Accreditation (AAAHC, JCAHO)
  39. Infection control standards

  40. Infusion Services


    The Biologics Opportunity

    IBD biologics represent significant revenue:

  41. Infliximab, vedolizumab, ustekinumab
  42. Professional fee: $150-300
  43. Drug margin: Varies by 340B status and payer
  44. Patient convenience factor

  45. Setting Up Infusion

    Requirements:

  46. Dedicated infusion space
  47. RN staffing (1:3-4 patient ratio)
  48. Emergency protocols
  49. Drug inventory management

  50. Buy-and-Bill vs. Specialty Pharmacy

    Evaluate carefully:

  51. Payer mix matters enormously
  52. 340B eligibility changes economics
  53. Administrative burden of buy-and-bill
  54. White bagging trends

  55. Clinical Operations


    Office Visit Efficiency

    Balance volume and quality:

  56. New GI consult: 30-45 minutes
  57. Follow-up: 15-20 minutes
  58. IBD complex: 30 minutes
  59. Procedure consent: Bundle with visit

  60. MA Scope of Practice

    Train MAs for GI-specific tasks:

  61. Medication reconciliation (complex in GI)
  62. Prior auth initiation
  63. Patient education
  64. Procedure prep instructions

  65. Revenue Cycle for GI


    Key Focus Areas

  66. Procedure coding accuracy Modifier usage critical
  67. Pathology coordination Ensure billing integration
  68. Biologic authorization High-dollar, high-scrutiny
  69. Screening vs. diagnostic coding Impacts patient cost-sharing

  70. Common Coding Issues

  71. Colonoscopy with polypectomy coding
  72. Moderate sedation billing
  73. Specimen handling charges
  74. Split reimbursement scenarios

  75. Quality and Outcomes


    Key GI Metrics

  76. Adenoma detection rate (target >25%)
  77. Cecal intubation rate (target >95%)
  78. Complication rates
  79. Patient satisfaction

  80. MIPS Considerations

    GI-specific measures available:

  81. Colorectal cancer screening
  82. Barrett's surveillance
  83. Hepatitis C screening
  84. IBD assessment measures

  85. Growth Strategies


    Geographic Expansion

  86. Satellite endoscopy centers
  87. Clinic-only locations in underserved areas
  88. Hospital partnerships for complex procedures

  89. Service Line Development

    Consider adding:

  90. Hepatology focus
  91. Motility services
  92. Nutrition counseling
  93. Advanced endoscopy (EUS, ERCP if trained)

  94. Ready to optimize your GI practice? We have extensive experience helping gastroenterology groups maximize their operational and financial performance.


    gastroenterologyGI practiceendoscopyASCinfusioncolonoscopy

    About the author

    Peter Kemp

    Managing Partner

    Peter Kemp is a healthcare operations executive with more than 15 years of leadership experience spanning physician practice management, private-equity–backed startups, and multispecialty clinical organizations.

    Read full bio
    Share this article

    Related Articles

    Ready to Transform Your Practice?

    Schedule a discovery call to discuss how we can help your practice implement these strategies and achieve real results.